Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fasudil hydrochloride (HA-1077) 是一种非特异性RhoA/ROCK 抑制剂,也抑制蛋白激酶,对 ROCK1、PKA、PKC 和 MLCK 的 Ki 值分别为 0.33 μM、1.0 μM、9.3 μM 和 55 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 248 | 现货 | ||
100 mg | ¥ 428 | 现货 | ||
200 mg | ¥ 591 | 现货 | ||
500 mg | ¥ 992 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 148 | 现货 |
产品描述 | Fasudil hydrochloride (HA-1077) is a potent inhibitor of ROCK1, PKA, PKC, and MLCK with Ki of 0.33 μM, 1.0 μM, 9.3 μM and 55 μM, respectively. |
靶点活性 | ROCK1:0.33 μM(ki), PKC:9.3 μM(ki), PKA:1.0 μM(ki), MLCK:55 μM(ki) |
体外活性 | 静脉注射0.01,0.03,0.1 和 0.3 mg/kg Fasudil剂量依赖性地降低MBP,提高HR,VBF,CBF,RBF和FBF.总剂量为1.0 ng/mL的 Fasudil提高心脏的输出量.通过冠状动脉内注射给实验狗30 μg Fasudil导致CBF增加约50%.口服Fasudil(剂量为100 mg/kg/天)显著降低用PLP p139-151免疫的SJL/J小鼠中EAE的发病率和平均最大临床评分.Fasudil抑制小鼠脾细胞对抗原的增殖反应.Fasudil处理显示心血管疾病的保护作用,并减少JNK的激活和减少AIF在缺血性损伤下的线粒体核移位. |
体内活性 | Fasudil诱导肌动蛋白纤维解体,且抑制细胞迁移。Fasudil竞争性抑制Ca2+诱导的去极化兔主动脉收缩。Fasudil抑制对KCl,血清苯丙氨酸和前列腺素F2a的收缩反应。Fasudil抑制肝星状细胞的扩散,应力纤维的形成和α-SMA的表达,且抑制细胞生长,但不诱导细胞凋亡。Fasudil抑制LPA诱导的ERK1/2,JNK 和 p38 MAPK磷酸化。Fasudil还通过抑制5-羟色胺,去甲肾上腺素,组胺,血管紧张素和多巴胺诱导的螺旋条收缩来发挥血管舒张作用。 |
激酶实验 | Cyclic AMP-dependent protein kinase activity is assayed in a reaction mixture containing, in a final volume of 0.2 mL, 50 mM Tris-HCl (pH 7.0), 10 mM magnesium acetate, 2 mM EGTA, 1 μM cyclic AMP or absence of cyclic AMP, 3.3 to 20 μM [r-32P] ATP (4×105 c.p.m.), 0.5 μg of the enzyme, 100 μg of histone H2B and compound. The mixture is incubated at 30°C for 5 min. The reaction is terminated by adding 1mL of ice-cold 20% trichloroacetic acid after adding 500 μg of bovine serum albumin as a carrier protein. The sample is centrifuged at 3000 r.p.m. for 15min, the pellet is resuspended in ice-cold 10% trichloro-acetic acid solution and the centrifugation-resuspension cycle is repeated three times. The final pellet is dissolved in 1 mL of 1 N NaOH and radioactivity is measured with a liquid scintillation counter. |
别名 | Fasudil (HA-1077) HCl, 盐酸法舒地尔, HA-1077, Fasudil HCl, HA-1077 hydrochloride, AT-877 |
分子量 | 327.83 |
分子式 | C14H18ClN3O2S |
CAS No. | 105628-07-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 32.8 mg/mL (100 mM)
DMSO: 24.6 mg/mL (75 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.0504 mL | 15.2518 mL | 30.5036 mL | 76.259 mL |
5 mM | 0.6101 mL | 3.0504 mL | 6.1007 mL | 15.2518 mL | |
10 mM | 0.305 mL | 1.5252 mL | 3.0504 mL | 7.6259 mL | |
20 mM | 0.1525 mL | 0.7626 mL | 1.5252 mL | 3.813 mL | |
50 mM | 0.061 mL | 0.305 mL | 0.6101 mL | 1.5252 mL | |
H2O | 100 mM | 0.0305 mL | 0.1525 mL | 0.305 mL | 0.7626 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Fasudil hydrochloride 105628-07-7 Autophagy Cell Cycle/Checkpoint Chromatin/Epigenetic Cytoskeletal Signaling Membrane transporter/Ion channel Metabolism Microbiology/Virology Proteases/Proteasome Stem Cells Tyrosine Kinase/Adaptors ROCK Calcium Channel Serine/threonin kinase HIV Protease PKA PKC TWNT-4 cells TIMP-1 HA 1077 a-SMA Protein kinase A Ca channels HIV rat HSCs AT877 Rho-associated protein kinase human HSC ERK1/2 Rho-kinase inhibit Ca2+ channels Rho-associated kinase HA1077 Hydrochloride Fasudil (HA-1077) HCl p38 lysophoaphatidic acid Fasudil 盐酸法舒地尔 Ca2+ channel antagonist JNK HA 1077 Hydrochloride HA-1077 protein kinases collagen LPA HA1077 Inhibitor Fasudil HCl Fasudil Hydrochloride Protein kinase C vasodilator ROK HA-1077 hydrochloride AT 877 Human immunodeficiency virus orally active AT-877 HA-1077 Hydrochloride inhibitor